OshudBD
Zukaria 5 mg Packaging
Click to zoom
DGDA Registration: DGDA Certified
Authentic Manufacturer Packaging
Sublingual Tablet 5 mg

Zukaria

Manufactured by: Incepta Pharmaceuticals Ltd.
Retail Price (MRP)
৳30.00 / unit
Pack: ৳900.00 (3 x 10) Strip: ৳300.00
🧮
Prescription Course & Cost Estimator
Estimate total required medicine count and pharmacy bill for your prescription
Daily Dose:
Duration:
Total Quantity 14 Sublingual Tablet
Estimated Prescription Bill ৳420.00

Cheaper & Alternative Brands

Same generic (Asenapine Maleate), same form (Sublingual Tablet)

No other brands currently registered with this exact active generic and dosage form.

Clinical Prescribing Information

Medical monograph and safety information for healthcare professionals & patients.
📋

Indications & Clinical Uses

Zukaria is indicated for:
Schizophrenia in adults
Bipolar I disorder
Acute monotherapy for manic or mixed episodes in adults and pediatric patients 10 to 17 years of age
Adjunctive treatment to lithium or valproate in adults.
Maintenance monotherapy treatment in adults

💊

Dosage & Administration

Schizophrenia: adults:
Initial dose: 5 mg sublingually, twice daily
Recommended dose: 5 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Schizophrenia maintenance treatment in adults.
Initial dose: 5 mg sublingually, twice daily
Recommended dose: 5-10 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Bipolar mania in adults: acute and maintenance monotherapy.
Initial dose: 5-10 mg sublingually, twice daily
Recommended dose: 5-10 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Bipolar mania in pediatric patients (10-17 years): monotherapy.
Initial dose: 2.5 mg sublingually, twice daily
Recommended dose: 2.5-10 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Bipolar mania in adults: as an adjunct to lithium or valproate
Initial dose: 5 mg sublingually, twice daily
Recommended dose: 5-10 mg sublingually, twice daily
Maximum dose: 10 mg sublingually, twice daily
Sublingual tablets should not be swallowed. It should be placed under the tongue and left to dissolve completely. It will dissolve in saliva within seconds. Eating and drinking should be avoided for 10 minutes after administration.

⚠️

Contraindications

Asenapine is contraindicated in patients with:
Severe hepatic impairment (Child-Pugh C).
A history of hypersensitivity reactions to asenapine. Reactions have included anaphylaxis, angioedema, hypotension, tachycardia, swollen tongue, dyspnea, wheezing and rash.

Side Effects & Adverse Reactions

The most common adverse reactions to asenapine are akathisia, somnolence, oral hypoesthesia, dizziness, extrapyramidal symptoms, nausea, increased appetite, fatigue, and increased weight.

🛡️

Warnings & Precautions

Caution should be exercised when asenapine is prescribed in elderly patients with dementia-related psychosis, QT prolongation, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, orthostatic hypotension, leukopenia, neutropenia, agranulocytosis, seizures, and the potential for cognitive and motor impairment.

🔬

Pharmacology & Mechanism of Action

The mechanism of action of asenapine, in schizophrenia and bipolar I disorder, is unknown. It has been suggested that the efficacy of asenapine in schizophrenia could be mediated through a combination of antagonist activity at D2 and 5-HT 2A receptors.

Medical Disclaimer: The clinical monographs, pricing, and formulations on OshudBD are compiled for reference and informational purposes only. Always seek the advice of a registered physician regarding any medical treatment.
Zukaria ৳30.00 / unit
Search
Link copied to clipboard!